| 1 |
33796452 | Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study. | 2021 |
1 |
| 2 |
32232697 | The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer. | 2020 May |
2 |
| 3 |
33050010 | Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy. | 2020 Oct 8 |
1 |
| 4 |
29039120 | Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010. | 2018 Jan |
1 |
| 5 |
29937187 | High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes. | 2018 Jun |
1 |
| 6 |
30402236 | Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer. | 2018 Nov |
1 |
| 7 |
22252257 | Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. | 2012 Jan 15 |
2 |
| 8 |
22987085 | Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma. | 2012 Nov 10 |
1 |
| 9 |
21597921 | Biologic markers determine both the risk and the timing of recurrence in breast cancer. | 2011 Sep |
1 |
| 10 |
11948499 | Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy. | 2002 May 1 |
2 |